Actively Recruiting

Phase 3
Age: 18Years +
All Genders
NCT06391242

Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Non-Spine Bone Metastases

Led by Canadian Cancer Trials Group · Updated on 2026-03-27

230

Participants Needed

7

Research Sites

147 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is being done to answer the following question: Is Stereotactic Body Radiation Therapy or SBRT (a form of radiation therapy which can deliver high doses of radiation to the specific painful area of the body most affected by cancer, while keeping the radiation beams away from the healthy parts of the body that surround the cancer) better for pain relief than the standard treatment of conventional radiation therapy or CRT (a form of radiation therapy which delivers radiation to the painful area but can also negatively affect other parts of the body in the same area)

CONDITIONS

Official Title

Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Non-Spine Bone Metastases

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Histologic confirmation of solid tumour
  • Presence of a dominant painful non-spine bone metastasis with a worst minimum pain score of 2 or greater
  • Expected survival longer than 6 months as assessed by the treating doctor
  • Suitable for both SBRT and conventional radiation treatments as defined by the study
  • Stable pain without plans to change pain medication
  • ECOG performance status between 0 and 2
  • Signed informed consent according to local and regulatory rules
Not Eligible

You will not qualify if you...

  • Bone metastases located in the hands, feet, skull, spine, or sacrum as the primary painful site
  • Bone metastases originating from small cell or germ cell tumors
  • Radionuclide therapy received within 30 days before randomization
  • Prior palliative radiation therapy to the dominant painful bone metastasis site (unless before metastasis development)
  • Chemotherapy received within 1 week before or planned within 1 week after radiation therapy
  • Unstable pathological fracture at the painful bone metastasis or preference for surgical fixation
  • Pregnancy or lactation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 7 locations

1

Kingston Health Sciences Centre

Kingston, Ontario, Canada, K7L 2V7

Actively Recruiting

2

London Health Sciences Centre Research Inc.

London, Ontario, Canada, N6A 5W9

Actively Recruiting

3

Stronach Regional Health Centre at Southlake

Newmarket, Ontario, Canada, L3Y 2P9

Actively Recruiting

4

Odette Cancer Centre

Toronto, Ontario, Canada, M4N 3M5

Actively Recruiting

5

University Health Network

Toronto, Ontario, Canada, M5G 2M9

Actively Recruiting

6

CHUM-Centre Hospitalier de l'Universite de Montreal

Montreal, Quebec, Canada, H2X 3E4

Actively Recruiting

7

Hotel-Dieu de Quebec

Québec, Quebec, Canada, G1R 2J6

Actively Recruiting

Loading map...

Research Team

W

Wendy Parulekar

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here